- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
RHHBY.PK Market Currents
more »
-
May 15 Roche (RHHBY.PK) has won the right for its crenezumab Alzheimer's drug to take part in a study that will assess whether it can be used as a preventative treatment. Crenezumab will be tested on an extended Colombian family of about 5,000 people who carry a gene that causes them to develop Alzheimer's early.
Comment![Healthcare]
RHHBY.PK in Focus
more »
RHHBY.PK Related Articles
more »
RHHBY.PK News
more »
-
at CNBC.com (Feb 21, 2012)
-
at CNBC.com (Oct 8, 2010)
RHHBY.PK Press Releases and Filings
more »
Currently, there are no press releases or filings on RHHBY.PK.
RHHBY.PK Latest Transcript
more »
RHHBY.PK Cramer
more »
-
Thu, Jan 26
-
Sun, Nov 8, 2009
-
Fri, Mar 13, 2009
RHHBY.PK Instablog posts
more »
RHHBY.PK vs. ETF Alternatives
Company Description
Currently, there's no company description for RHHBY.PK.